Tough to get new investors when the overall outlook of the market is crap. Dr S definitely has more news in the tank and will release it in a timely manner to keep the price driving up. The latest PR wasn't even that much of a head-turner but contained keywords such as FDA and such. These are still very early days. We know the primary ingredient will get approved because it is the same as Viagra. The sublingual elements are key and once they can perfect that, they can apply it to the line of other drugs they have waiting in the shadows. Trials are a lengthy process.